Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.
Madireddi S, Eun SY, Lee SW, Nemčovičová I, Mehta AK, Zajonc DM, Nishi N, Niki T, Hirashima M, Croft M.
Madireddi S, et al. Among authors: nishi n.
J Exp Med. 2014 Jun 30;211(7):1433-48. doi: 10.1084/jem.20132687. Epub 2014 Jun 23.
J Exp Med. 2014.
PMID: 24958847
Free PMC article.